Get started
Author

Sovira Chaudhry

Chemotherapy-Induced Cognitive Impairment Is Associated with Increased Inflammation and Oxidative Damage in the Hippocampus
2019 · Ciara Bagnall-Moreau, Sovira Chaudhry, et al. · Molecular Neurobiology · 117
Glutaminase inhibition in combination with azacytidine in myelodysplastic syndromes: a phase 1b/2 clinical trial and correlative analyses
2024 · Courtney D. DiNardo, Divij Verma, et al. · Nature Cancer · 48
PDF
Efficacy of a novel BCL-xL degrader, DT2216, in preclinical models of JAK2 -mutated post-MPN AML
2025 · Zhe Wang, Anna Skwarska, et al. · Blood · 30
Abstract 7201: Targeting SLC38A1 non-conventional glutamine transporter in high risk MDS/AML
2025 · Akansha Jalota, Anna Skwarska, et al. · Cancer Research · 1
Efficacy of a Novel BCL-XL Degrader, DT2216, in Preclinical Models of Post-Myeloproliferative Neoplasm Secondary AML
2024 · Zhe Wang, Anna Skwarska, et al. · Blood · 1
PDF
Specific F 1 ATP synthase inhibition delivers transient mitochondrial stress for selective targeting of acute myeloid leukemia
2026 · Matthew T. Villaume, Haley E. Ramsey, et al. · bioRxiv (Cold Spring Harbor Laboratory)
PDF
Abstract 1841: Venetoclax rewires Notch signaling to drive resistance in North American adult T-cell leukemia/lymphoma.
2026 · Ankit Tanwar, Salman Sadullah Usmani, et al. · Cancer Research
Abstract 7107: Dual FLT3/BRAF inhibitor PHI3 overcomes RAS-driven resistance in FLT3-mutant AML
2026 · Shikhar Sharma, Anna Skwarska, et al. · Cancer Research
EB2023 primes mitochondria for BCL2 dependence and induces pyroptotic cell death via AMPK signaling and the unfolded protein response
2025 · Matthew Villaume, Michael Davidson, et al. · Blood
PDF
Abstract 3049: Synergistic growth-inhibitory efficacy of LSD1 and BCL-XL inhibitors in JAK2+ AML/MPN cells
2025 · Mark A. Forsberg, Zhe Wang, et al. · Cancer Research
Targeting PERK Arm of Unfolded Protein Response Helps to Eliminate Therapy-Induced Residual Senescent-like Acute Myeloid Leukemia Cells
2024 · Gowri Poigaialwar, Sumiko Takao, et al. · Blood
PDF
Venetoclax Synergizes with IMGN632, a Novel CD123-Targeting Antibody Conjugated to a DNA Alkylating Payload, By Suppressing DNA Damage Response and Potentiating Apoptosis in Acute Myeloid Leukemia in Vitro Models
2023 · Anna Skwarska, Vinitha Mary Kuruvilla, et al. · Blood
PDF
Works count: 12
Citation count: 197
H-index: 3
I10-index: 3
Year
Topic
Type